Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Clinical trial NCT03614728 · TERMINATED
Trial details
- NCT number
- NCT03614728
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-16
- Primary completion
- 2022-01-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.